Interleukin‐1α Mediates Pancreatic Fibroblast Activation, Regulates Immune Cell Recruitment and Fibrosis in Acute and Chronic Pancreatitis
Open Access
- 3 September 2026
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (64)
Abstract
Pancreatitis is a life‐threatening inflammatory disease of the pancreas. The cytokine interleukin‐1α has been demonstrated to act as an alarmin released by necrotic cells. In the present study, we investigated the influence of IL‐1α on the immune response during acute and chronic pancreatitis. Following tissue injury, pancreatic acinar cells released IL‐1α, which activates tissue‐resident fibroblasts to differentiate toward a pro‐inflammatory phenotype. By secreting chemokines and cytokines such as CXCL5, CCL2, and IL‐6, these fibroblasts recruit immune cells to the pancreas. The absence of IL‐1α reduces disease severity in acute pancreatitis and chemokine release. Furthermore, IL‐1α primes fibroblasts to enhance the production of extracellular matrix‐components by the up‐regulation of pro‐fibrotic receptors such as Il4ra , Il13ra1 , and Tgfbr3 . Therefore, the deletion of IL‐1α significantly reduced the development of tissue fibrosis. A therapeutic blockade of the IL1R1‐signaling by i.p. administration of the IL‐1‐receptor antagonist Anakinra showed the same effect; the severity of acute pancreatitis and fibrogenesis during chronic pancreatitis were reduced. In conclusion, the crosstalk between necrotic acinar cells and fibroblasts mediated by IL‐1α plays a crucial role in acute inflammation of the pancreas and fibrogenic signaling. Blockade of IL1R1‐signaling by Anakinra is therefore a promising therapeutic intervention for both acute and chronic pancreatitis.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (DFG SE 2702/2‐3)
- Deutsche Forschungsgemeinschaft (DFG SE 2702/4‐1)
- Deutsche Forschungsgemeinschaft (GL 1096/1‐1)
- Deutsche Forschungsgemeinschaft (ZI 2071/2‐1)
- Deutsche Forschungsgemeinschaft (GRK 2719 A1 C1)
- Deutsche Forschungsgemeinschaft (RTG 2901 SYLOBIO)
This publication has 33 references indexed in Scilit:
- IL‐4/STAT6‐signaling Influences Local Inflammation and Regeneration Processes During Acute Pancreatitis and Promotes Fibrosis by a Direct Activation of Pancreatic Fibroblasts During Chronic PancreatitisAdvanced Science, 2026
- Exploring TGFBR3 in disease pathogenesis: Mechanisms, clinical implications, and pharmacological modulationJournal of Pharmaceutical Analysis, 2025
- Macrophage phenotypic switch orchestrates the inflammation and repair/regeneration following acute pancreatitis injuryEBioMedicine, 2020
- Improving Proteome Coverage for Small Sample Amounts: An Advanced Method for Proteomics Approaches with Low Bacterial Cell NumbersProteomics, 2019
- Interleukin 1α and the inflammatory processNature Immunology, 2016
- Necroptosis Is an Important Severity Determinant and Potential Therapeutic Target in Experimental Severe PancreatitisCellular and Molecular Gastroenterology and Hepatology, 2016
- Alternatively activated macrophages promote pancreatic fibrosis in chronic pancreatitisNature Communications, 2015
- IL-1α released from damaged epithelial cells is sufficient and essential to trigger inflammatory responses in human lung fibroblastsMucosal Immunology, 2014
- NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in miceHepatology, 2013
- Interleukin-4 induces the activation and collagen production of cultured human intrahepatic fibroblasts via the STAT-6 pathwayLaboratory Investigation, 2008